« Previous
Next »
Seminars in Oncology Nursing
Volume 22, Issue 2
, Pages 107-116
, May 2006
Hematopoietic Cell Transplantation in Non-Hodgkin’s Lymphoma
References
-
.
Cancer Facts and Figures 2006
. Atlanta, GA: American Cancer Society; 2006;
-
Long-term follow-up of patients with low grade malignant lymphoma treated with doxorubicin based chemotherapy or chemoimmunotherapy
.
J Clin Oncol
. 1993;11:
664-651
- . Comparison of sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo . J Natl Cancer Inst . 1965;37:233–245
- Prolonged complete remission following high dose chemotherapy of Burkitt’s lymphoma in relapse . Cancer . 1978;41:1059–1063
- . High dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin’s lymphoma . J Clin Oncol . 1993;11:1846–1851
- BEAM chemotherapy and autologous bone marrow transplantation for patients with relapsed or refractory non-Hodgkin’s lymphoma . J Clin Oncol . 1995;13:588–595
- . High-dose therapy and autologous bone marrow transplantation after failure of conventional chemotherapy in adults with intermediate-grade or high-grade non-Hodgkin’s lymphoma . N Engl J Med . 1987;316:1493–1498
- Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin’s lymphoma . N Engl J Med . 1995;333:1540–1545
- Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial . J Clin Oncol . 1998;16:3264–3269
- Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate-grade and high-grade non-Hodgkin’s lymphoma in first complete remission (A study of 464 patients) . J Clin Oncol . 2004;12:2543–2551
- Autologous bone marrow transplantation for patients with poor prognosis lymphoma . J Clin Oncol . 1988;6:1303–1313
- Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor risk intermediate and high grade lymphoma. International index high and high-intermediate risk group . Blood . 1997;90:3844–3852
- . Bone marrow transplantation for non-Hodgkin’s lymphoma (A review) . Am J Med Sci . 1997;313:228–235
- Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma . Blood . 1999;94:3325–3333
- High-dose therapy and autologous cell transplantation for follicular lymphoma beyond first remission (The Stanford University experience) . Biol Blood Marrow Transplant . 2001;7:294–301
- All advanced stage non-Hodgkin’s lymphomas with polymerase chain reaction amplification breakpoint of bcl-2 have residual cells containing bcl-2 rearrangement at evaluation after treatment . Blood . 1991;78:3275–3280
- Detection of occult lymphoma in the peripheral blood and bone marrow of patients with untreated early-stage and advanced-stage follicular lymphoma . J Clin Oncol . 1993;11:1344–1352
-
.
Autologous stem cell transplantation for mantle cell lymphoma
(A report of 69 patients from City of Hope and Stanford (abstract))
.
Proc Am Soc Hematol
. 2002;100:182a
- High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma . Blood . 2002;99:3158–3162
- Impact of high-dose chemotherapy on peripheral T-cell lymphomas . J Clin Oncol . 2001;19:3766–3770
- . Acquired immunodeficiency syndrome-related lymphoma (Clinical aspects) . Semin Oncol . 2000;27:442–453
- Low dose compared with standard dose m-BACOD chemotherapy for non-Hodgkin’s lymphoma associated with human immunodeficiency virus infection . N Engl J Med . 1997;366:1641–1648
- . Progression of human immunodeficiency virus type-1 infection after allogeneic marrow transplantation . Am J Med . 1990;88:49N–52N
- Autologous bone marrow transplantation in relapsed HIV-related non-Hodgkin’s lymphoma . Bone Marrow Transplant . 1996;18:1195–1197
- T-cell immune reconstitution after hematopoietic stem cell transplantation of HIV associated lymphoma . Transplantation . 2005;80:673–682
- High-dose therapy improved progression-free survival and survival in relapsed follicular non-Hodgkin’s lymphoma (Results from the randomized European CUP trial) . J Clin Oncol . 2003;21:3918–3927
- Purging of bone marrow in autologous bone marrow transplantation for non-Hodgkin’s lymphoma (A case-matches comparison with unpurged cases by the European blood and marrow transplant lymphoma registry) . J Clin Oncol . 1996;14:2454–2464
- Phase I clinical trial using escalating single-dose infusion of chimeric anti-CD20 monoclonal antibody (IDEC-C2B8) in patients with recurrent B cell lymphoma . Blood . 1994;83:435–445
- Autologous transplantation for aggressive non-Hodgkin’s lymphoma (Results of a randomized trial evaluating graft source and minimal residual disease) . J Clin Oncol . 2002;20:2344–2352
- Progenitor and lymphoma cells in blood stem cell harvests (Impact on survival following transplantation) . Bone Marrow Transplant . 2001;28:207–212
- Culture methods for the detection of minimal tumor contamination of hematopoietic harvests (A review) . J Hematother . 1995;4:141–148
- Peripheral blood for solid tumors and lymphomas (Hematologic recovery and costs – A randomized controlled trial) . Ann Intern Med . 1997;126:600–607
- Randomized trial of Filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients . Lancet . 1996;347:353–357
- Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin’s lymphoma . Blood . 1997;90:4201–4205
- Allogeneic bone marrow transplantation for low grade lymphoma . Blood . 1998;92:1832–1836
-
.
Autologous hematopoietic cell transplantation for non-Hodgkin’s lymphoma
.
In:
Thomas ED
, Blume K
, Forman S
editor.
Hematopoietic Cell Transplantation
. Malden, MA: Blackwell Sciences; 1994;p. 939–949
- A phase I-II trial of iodine-131-tositumomab (anti CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas . Blood . 2000;96:2934–2942
- Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-sell rescue . J Clin Oncol . 1998;16:3270–3278
-
.
Specialized nursing
.
In:
Ball ED
, Lister J
, Law P
editor.
Hematopoietic Stem Cell Therapy
. New York, NY: Churchill Livingstone; 2000;p. 683–687
-
.
Graft versus disease versus graft-versus host disease
.
In:
Improving the therapeutic index
. Alexandria, VA: American Society of Clinical Oncology 2002 Spring Education; 2002;p. 62–67
-
.
Graft versus host disease
.
In:
Ezzone S
editors.
Hematopoietic Stem Cell Transplantation
(A Manuel for Nursing Practice)
. Pittsburgh, PA: Oncology Nursing Society; 2004;p. 85–131
-
.
Patient and family caregiver teaching
.
In:
Buchsel P
, Kapustay PM
editor.
Stem Cell Transplantation
(A clinical Textbook)
. Pittsburgh, PA: Oncology Nursing Society; 2000;p. 6.1–6.11
-
.
Bone marrow transplantation
.
In:
Miaskowski C
, Buchsel P
editor.
Oncology Nursing
(Assessment and Clinical Care)
. St Louis, MO: Mosby; 1999;p. 143–186
-
.
Post transplant follow up
.
In:
Ezzone S
editors.
Hematopoietic Stem Cell Transplantation
(A Manuel for Nursing Practice)
. Pittsburgh, PA: Oncology Nursing Society; 2004;p. 207–220
-
.
Quality of life issues in hematopoietic stem cell transplantation
.
In:
Ezzone S
editors.
Hematopoietic Stem Cell Transplantation
(A Manuel for Nursing Practice)
. Pittsburgh, PA: Oncology Nursing Society; 2004;p. 237–248
-
.
Allogeneic transplantation for lymphoma and chronic lymphocytic leukemia
.
In:
Blume K
, Forman S
, Applebaum F
editor.
Thomas’ Hematopoietic Cell Transplantation
. Malden, MA: Blackwell; 2004;p. 1104–1113
PII: S0749-2081(06)00015-5
doi: 10.1016/j.soncn.2006.01.006
© 2006 Elsevier Inc. All rights reserved.
« Previous
Next »
Seminars in Oncology Nursing
Volume 22, Issue 2
, Pages 107-116
, May 2006
